Copyright 2018 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25.32% per year. These returns cover a period from January 1, 1988 through November 5, 2018. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.
Visit performance for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
medical: Archive
New Strong Sell Stocks for December 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
ADNT ACM ACHC AAC ACU
consumer-discretionary industrial-products medical
Magellan Health (MGLN) Surges: Stock Moves 6.7% Higher
by Zacks Equity Research
Magellan Health (MGLN) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
MGLN HUM
medical
Do Options Traders Know Something About Intrexon (XON) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Intrexon (XON) stock based on the movements in the options market lately.
XON
medical
Do Options Traders Know Something About Neurocrine Biosciences (NBIX) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Neurocrine Biosciences (NBIX) stock based on the movements in the options market lately.
NBIX
medical
Do Options Traders Know Something About Clovis (CLVS) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Clovis (SFIX) stock based on the movements in the options market lately.
CLVS
medical
CONMED's Buffalo Filter Buyout Likely to be Accretive in 2020
by Zacks Equity Research
CONMED's (CNMD) comprehensive surgical smoke evacuation portfolio lends it a competitive edge in the industry.
ITGR OPK SYK CNMD
medical
Anika Therapeutics Enters Oversold Territory
by Zacks Equity Research
Anika Therapeutics has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
ANIK
medical
Applied Genetic Technologies Enters Oversold Territory
by Zacks Equity Research
Applied Genetic Technologies has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
AGTC
medical
The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance
GFN PEN VNDA GIII
medical
Zacks.com featured highlights include: Verint Systems, Integer, AMN Healthcare Services, Xilinx and United States Cellular
by Zacks Equity Research
Zacks.com featured highlights include: Verint Systems, Integer, AMN Healthcare Services, Xilinx and United States Cellular
AMN VRNT ITGR USM XLNX
medical
The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
NEO ANTM ENSG MMSI MEDP
medical
Here's Why You Should Hold Allscripts Stock in Your Portfolio
by Zacks Equity Research
Allscripts (MDRX) has been winning contracts in the Sunrise EHR platform; competition stiff.
MDRX QDEL ILMN STAA
medical
Hologic's (HOLX) New Offering to Revitalize Cynosure Division
by Zacks Equity Research
The latest launch along with certain new developments is expected to boost top-line contribution from Hologic's (HOLX) Cynosure division in the near term.
VEEV HOLX ITGR SRDX
medical
The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron
EXC MMM ISRG HCA MU
medical
The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance
GFN PEN VNDA GIII
medical retail
New Strong Buy Stocks for December 14th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
ONVO OFIX ITGR ILMN BRKR
biotechs industrial-products medical
Top Analyst Reports for Comcast, American Express & Bristol-Myers
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), American Express (AXP) and Bristol-Myers (BMY).
TMUS GM CMCSA CAT BMY AXP
consumer-discretionary finance medical
Top Ranked Momentum Stocks to Buy for December 14th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 14th:
AINC AEYE ABMD
finance internet medical
Johnson and Johnson Shares Rocked by Asbestos Allegations
by David Borun
Shares fall 10% on reports company executives knew about harmful contamination
JNJ
medical
Bruker Profits from NANO & CALID, New Buyout Holds Promise
by Zacks Equity Research
Bruker (BRKR) looks to gain from high demand for ADVANCE X-ray and nano-analysis products. The CALID Group also raises hope with high-single digit robust year-to-date revenues.
VEEV BRKR ITGR SRDX
medical
Thermo Fisher (TMO) Rides on New Buyouts and APAC Strength
by Zacks Equity Research
We are upbeat about Thermo Fisher's (TMO) recent buyout of Advanced Bioprocessing business, which will add complementary cell culture products to the company's bioproduction suit.
VEEV TMO ITGR SRDX
medical
Express Scripts Announces 3-Year Agreement With Walmart
by Zacks Equity Research
Express Scripts (ESRX) and Walmart (WMT) collaborate to increase affordable access of the expensive prescription drugs for insured and uninsured patients.
QDEL STAA WMT ESRX
medical retail
5 Healthcare Bets to Stay in Investors Good Books Next Year
by Zacks Equity Research
Based on a few key factors, we zero in on five stocks that show promise to retain the bull run in 2019.
NEO ANTM ENSG MMSI MEDP
medical
Company News For Dec 13, 2018
by Zacks Equity Research
Companies In The News Are: AEO,PVTL,LOW,ATNX
LOW AEO PVTL ATNX
computers medical retail
The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis
CNAT EXEL GILD BIIB IONS
medical